Search Details

Word: vaccinees (lookup in dictionary) (lookup stats)
Dates: during 2000-2009
Sort By: most recent first (reverse)


Usage:

The vaccine, called RV144, combined two older vaccines that had each proved unsuccessful in previous tests: ALVAC, from Sanofi Pasteur, the vaccine division of French drugmaker Sanofi-Aventis; and AIDSVAX, originally developed by VaxGen Inc. and now held by the nonprofit Global Solutions for Infectious Diseases.

Author: /time Magazine | Title: AIDS-Vaccine Trial Raises Hopes — and Questions | 9/25/2009 | See Source »

The vaccine was administered in two stages. First the ALVAC vaccine, which uses a Frankenstein virus of canarypox and HIV, was used as a primer dose, then AIDSVAX was administered as a "booster" to improve the body's immune response to the first shot. Half of the trial's participants...

Author: /time Magazine | Title: AIDS-Vaccine Trial Raises Hopes — and Questions | 9/25/2009 | See Source »

An AIDS vaccine has been shown to reduce the risk of HIV infection in humans for the first time, a significant advance in a field of research that has long been stymied by failure.

Author: /time Magazine | Title: AIDS-Vaccine Trial Raises Hopes — and Questions | 9/25/2009 | See Source »

The $105 million, six-year trial, which involved more than 16,000 people in Thailand - the largest AIDS-vaccine trial ever conducted - found that an experimental vaccine was 31% effective in preventing HIV infection. The volunteer group in the study was representative of the general Thai adult population, including low...

Author: /time Magazine | Title: AIDS-Vaccine Trial Raises Hopes — and Questions | 9/25/2009 | See Source »

"The efficacy is a modest one. But it's the first time we've seen a positive signal of efficacy in a human trial of any HIV vaccine. That's an exciting result in a field that has been characterized by disappointments for two decades," says Anthony Fauci, director of...

Author: /time Magazine | Title: AIDS-Vaccine Trial Raises Hopes — and Questions | 9/25/2009 | See Source »

Previous | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | Next